Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07803978 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Randomized Controlled Study: Amimaitosai Injection Combined With Corticosteroids for Gastrointestinal aGVHD

Name: Prospective Randomized Controlled Study: Amimaitosai Injection Combined With Corticosteroids for Gastrointestinal aGVHD — clinical trial record (NCT07803978)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusEnrolling by Invitation

PhaseEarly Phase 1

SponsorChinese PLA General Hospital

Started2026-05-01

View on ClinicalTrials.gov ↗

Chinese PLA General Hospital

193 trials monitored

See 4 trials at risk

This study focuses on patients with gastrointestinal-dominant acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. AmiMetosai Injection combined with corticosteroids is administered as first-line treatment. The objective is to evaluate the efficacy and safety of AmiMetosai Injection combined with corticosteroids for the treatment of gastrointestinal aGVHD.

Trial Details

NCT Number	NCT07803978
Lead Sponsor	Chinese PLA General Hospital
Conditions	Acute Gastrointestinal Graft-versus-host Disease
Enrollment	60 participants
Start Date	2026-05-01
Primary Completion	2029-05-01 (estimated)
Study Completion	2029-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-04